N-acetyl-transferase phenotype and risk for preeclampsia.
until further notice
SourceAmerican Journal of Obstetrics and Gynecology, 193, 3 Pt 1, (2005), pp. 797-802
Article / Letter to editor
Display more detailsDisplay less details
American Journal of Obstetrics and Gynecology
iss. 3 Pt 1
SubjectEBP 1: Determinants in Health and Disease; EBP 2: Effective Hospital Care; IGMD 2: Molecular gastro-enterology and hepatology; ONCOL 3: Translational research; ONCOL 5: Aetiology, screening and detection; UMCN 5.2: Endocrinology and reproduction; UMCN 5.5: Nutrition and Health
OBJECTIVE: This study was undertaken to determine whether the N-acetyltransferase (NAT) phenotype contributes to the susceptibility for the development of preeclampsia. STUDY DESIGN: The NAT acetylator status was determined by measuring urinary caffeine metabolites in 134 nonpregnant women with a history of preeclampsia and in 109 control women with uncomplicated pregnancy. The chi(2) and logistic regression analyses were used for statistical evaluation of differences in acetylator status. RESULTS: Significantly more fast acetylators were found among the women with a history of preeclampsia (46.3%) than among the controls (25.4%). Fast acetylators showed an odds ratio of 2.5 (95% CI 1.4-4.3) for preeclampsia. No differences in the acetylator status were found between women with a history of preeclampsia only and those with the HELLP syndrome as well. CONCLUSION: The fast NAT acetylator status, which may result in altered NAT detoxification capacity, is associated with preeclampsia.
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.